title: ALLHAT: definitive answers or continuing uncertainty?
authors.affiliation: Imperial College London, NHLI Division, Department of Clinical Pharmacology, St Mary's Hospital, London, W2 1NY, UK. p.sever@ic.ac.uk
authors.forename: Peter
authors.initials: P
authors.lastname: Sever
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D006973:Hypertension / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents